Jagoni, Tarhata .
HRN: 01-88-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2023
CEFUROXIME 500MG (TAB)
03/01/2023
03/08/2023
PO
500 Mg
BID
T/C Incomplete Abortion
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes